DNA/RNA Extraction Industry is on an upward trajectory, with a projected CAGR of 7.4% between 2023 and 2033 | FMI

The DNA/RNA extraction market was expected to be worth US$ 1.3 billion in 2022 and US$ 1.40 billion in 2023. The DNA/RNA extraction market will grow at a CAGR of 7.4% between 2023 and 2033, reaching a value of over US$ 2.85 billion by 2033, according to Future Market Insights’ projections. The global adoption of DNA/RNA extraction in the healthcare sector is responsible for the market’s expansion.

The DNA/RNA extraction industry is a process of isolating DNA or RNA from cells and tissues. It is a critical step in many molecular biology and genetics techniques, including molecular diagnostics market demand, DNA sequencing, and gene cloning.

Request a Sample copy of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-10543

Key Factors Driving the Growth of the DNA/RNA Extraction Market:

• Increasing demand for molecular diagnostics: Molecular diagnostics are used to diagnose diseases, identify pathogens, and monitor disease progression. DNA/RNA extraction is a crucial step in most molecular diagnostic tests.
• Growing use of DNA sequencing: DNA sequencing is used to determine the order of nucleotides in a DNA molecule. It is used in a variety of research and clinical applications, including cancer genomics, infectious disease surveillance, and personalized medicine.
• Rising investments in gene cloning: Gene cloning is a technique used to produce multiple copies of a gene. It is used in research and development to study gene function and produce proteins for therapeutic purposes.

Key Trends in the DNA/RNA Extraction Market:

• Development of automated DNA/RNA extraction systems: Automated DNA/RNA extraction systems can improve the efficiency and accuracy of DNA/RNA extraction.
• Growing demand for point-of-care DNA/RNA extraction: Point-of-care DNA/RNA extraction systems allow for rapid and convenient DNA/RNA extraction, which is ideal for clinical settings.
• Increasing use of non-invasive DNA/RNA extraction methods: Non-invasive DNA/RNA extraction methods, such as liquid biopsy, are becoming increasingly popular, as they allow for DNA/RNA extraction from blood or other bodily fluids without the need for surgery.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-10543

Key Takeaways:

• The DNA/RNA extraction industry is expected to grow at a significant CAGR over the next decade, driven by the increasing demand for molecular diagnostics, DNA sequencing, and gene cloning.
• The high cost of DNA/RNA extraction kits, the need for skilled personnel, and the risk of contamination are some of the key challenges facing the market.
• The development of automated DNA/RNA extraction systems, the growing demand for point-of-care DNA/RNA extraction, and the increasing use of non-invasive DNA/RNA extraction methods are some of the key trends in the market.

Some of the prominent players in the global market are-

• Qiagen
• ThermoFisher Scientific Inc.
• F Hoffmann-La Roche AG
• Agilent Technologies
• Bio-Rad Laboratories Inc.
• Promega Corporation
• Danaher Corporation (Beckman Coulter Inc.)
• Merck & Co. Inc.
• PerkinElmer Inc.
• bioMérieux SA

Some of the important developments of the key players in the market are:

• In June 2023, Merck, known as MSD outside of the United States and Canada, had announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) acquisition where Prometheus is now a wholly-owned subsidiary of Merck and the common stock of Prometheus will no longer be listed or traded on the Nasdaq Global Market.
• In June 2023, Merck, known as MSD outside of the United States and Canada, announced that the Phase 3 KEYNOTE-811 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with trastuzumab and chemotherapy has met one of its dual primary endpoints of progression-free survival (PFS) for the first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Art of Personalization: Dive into the World of Customization with Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-10543

Key Segments Profiled in the DNA/RNA Extraction Industry Survey:

Product Type:

• Instruments
• Kits & Reagents
  • Genomic DNA Isolation & Purification Kits
  • Plasmid DNA Isolation & Purification Kits
  • Viral DNA Isolation & Purification Kits
  • Total RNA Isolation & Purification Kits
  • miRNA Isolation & Purification Kits
  • mRNA Isolation & Purification Kits
  • Total Nucleic Acid (RNA + DNA) Isolation & Purification Kits
  • Sequence-specific RNA Isolation & Purification Kits
  • Viral RNA Isolation & Purification Kits
• Others

Method:

• Reagent-based
• Column-based
• Magnetic Bead-based
• Other

Application:

• Oncology
• Precision Medicine
• Health & Diagnostics
• Drug Discovery & Development
• Agriculture
• Animal Research
• Other Applications

End User:

• Hospital Laboratories
• Academic & Research Laboratories
• Diagnostic Laboratories
• Biopharmaceutical Companies
• Forensic Laboratories
• Contract Research Organizations

Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• Japan
• Middle East & Africa

Get The Insights You Need to Stay Ahead of the Curve with Our Market Analysis Report. Act Now and Get An Exclusive Discount: https://www.futuremarketinsights.com/checkout/10543

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

Kidney Stone Extraction Balloon Market Size: Increasing from US$ 450.5 Million in 2022 to US$ 902.2 Million by 2032, the global kidney stone extraction market is expected to display a CAGR of 6.5% from 2022 to 2032.

Automated Nucleic Acid Extraction Systems Market Share: The automated nucleic acid extraction systems market is expected to grow at a CAGR of 10.9% from 2022 to 2032.

Extraction Kits Market Growth: The global demand for extraction kits is expected to increase at 7.1% CAGR over the forecast period. The extraction kits market size is estimated to reach a valuation of US$ 1,293.4 million by 2023. The market is estimated to reach US$ 2,556.6 million by 2033.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube